Advertisement

Secondary Prevention of Coronary Artery Disease with Omega-3 Fatty Acids

  • Terry A. Jacobson
    Correspondence
    Address for reprints: Terry A. Jacobson, MD, Department of Medicine, Emory University, 49 Jesse Hill Jr Drive SE, Atlanta, Georgia 30303.
    Affiliations
    Department of Medicine, Office of Health Promotion and Disease Prevention, Emory University School of Medicine, Atlanta, Georgia, USA.
    Search for articles by this author
      Omega-3 fatty acid therapy is a promising intervention for the secondary prevention of coronary artery disease (CAD). Omega-3 fatty acids have properties that promote atherosclerotic plaque stability and decrease the incidence of ischemia-driven cardiac arrhythmias. A large number of clinical trials conducted in patients with CAD or prior myocardial infarction (MI) have examined hard cardiovascular end points, including total mortality, cardiovascular mortality, sudden death, and nonfatal MI. Several intermediate cardiovascular end-point studies have also examined whether ventricular arrhythmias can be suppressed in patients with implantable cardioverter defibrillators (ICDs). Significant reductions in total mortality and sudden death—20% to 50%—have been found in studies using doses of 0.85 to 4.0 g/day, with treatment durations from 12 to 42 months. Favorable trends toward reduction in the incidence of arrhythmic events have been demonstrated in some, but not all, ICD studies. Omega-3 fatty acid therapy shows a general positive trend toward benefit in reducing life-threatening events after MI and in patients with ICDs who have ischemic arrhythmias. Results of the recent Japan EPA Lipid Intervention Study (JELIS) in a large cohort (N = 18,645) of Japanese men and women suggest significant benefits in the reduction of unstable angina and nonfatal coronary events. The totality of evidence supports a strong role for omega-3 fatty acids derived from fish oil in secondary prevention through a presumptive role as an antiarrhythmic agent and through an ability to promote plaque stabilization.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico (GISSI)-Prevenzione Investigators
        Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction.
        Lancet. 1999; 354 ([published correction appears in Lancet 2001;357:642]): 447-455
        • Marchioli R.
        • Barzi F.
        • Bomba E.
        • Chieffo C.
        • Di Gregoria D.
        • di Mascio R.
        • Fransosi G.
        • Geraci E.
        • Levantesi G.
        • Maggioni A.P.
        • et al.
        • GISSI-Prevenzione Investigators
        Early protection against sudden death by n-3 fatty acids after myocardial infarction.
        Circulation. 2002; 105: 1897-1903
        • Macchia A.
        • Levantesi G.
        • Franzosi M.G.
        • Geraci E.
        • Maggioni A.P.
        • Marfisi R.
        • Nicolosi G.L.
        • Schweiger C.
        • Tavazzi L.
        • Tognoni G.
        • et al.
        • GISSI-Prevenzione Investigators
        Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
        Eur J Heart Fail. 2005; 7: 904-909
        • Studer M.
        • Briel M.
        • Leimenstoll B.
        • Glass T.R.
        • Bucher H.C.
        Effect of different antilipidemic agents and diets on mortality.
        Arch Intern Med. 2005; 165: 725-730
        • Bucher H.C.
        • Hengstler P.
        • Schindler C.
        • Meier G.
        N-3 polyunsaturated fatty acids in coronary heart disease.
        Am J Med. 2002; 112: 298-304
        • Raitt M.H.
        • Connor W.E.
        • Morris C.
        • Kron J.
        • Halperin B.
        • Chugh S.S.
        • McClelland J.
        • Cook J.
        • MacMurdy K.
        • Swenson R.
        • et al.
        Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators.
        JAMA. 2005; 293: 2884-2891
        • Burr M.L.
        • Fehily A.M.
        • Gilbert J.F.
        • Rogers S.
        • Holliday R.M.
        • Sweetnam P.M.
        • Elwood P.C.
        • Deadman N.M.
        Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction.
        Lancet. 1989; 2: 757-761
        • Singh R.B.
        • Niaz M.A.
        • Sharma J.P.
        • Kumar R.
        • Rastogi V.
        • Moshiri M.
        Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction.
        Cardiovasc Drugs Ther. 1997; 11: 485-491
        • Nilsen D.W.
        • Albrektsen G.
        • Landmark K.
        • Moen S.
        • Aarsland T.
        • Woie L.
        Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol.
        Am J Clin Nutr. 2001; 74: 50-56
        • von Schacky C.
        • Angerer P.
        • Kothny W.
        • Theisen K.
        • Mudra H.
        The effect of dietary omega-3 fatty acids on coronary atherosclerosis.
        Ann Intern Med. 1999; 130: 554-562
        • Leng G.C.
        • Lee A.J.
        • Fowkes F.G.
        • Jepson R.G.
        • Lowe G.D.
        • Skinner E.R.
        • Mowat B.F.
        Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease.
        Clin Nutr. 1998; 17: 265-271
        • Sacks F.M.
        • Stone P.H.
        • Gibson C.M.
        • Silverman D.I.
        • Rosner B.
        • Pasternak R.C.
        • HARP Research Group
        Controlled trial of fish oil for regression of human coronary atherosclerosis.
        J Am Coll Cardiol. 1995; 25: 1492-1498
      1. Yokoyama M. Effects of eicosapentaenoic acid (EPA) on major cardiovascular events in hypercholesterolemic patients: the Japan EPA Lipid Intervention Study (JELIS). Presented at the American Heart Association Scientific Sessions; November 14, 2005; Dallas, TX.

        • Yokoyama M.
        • Origasa H.
        • JELIS Investigators
        Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia.
        Am Heart J. 2003; 146: 613-620
        • Leaf A.
        • Xiao Y.F.
        • Kang J.X.
        • Billman G.E.
        Prevention of sudden cardiac death by omega-3 polyunsaturated fatty acids.
        Pharmacol Ther. 2003; 98: 355-377
        • Siscovick D.S.
        • Raghunathan T.
        • King I.
        • Weinmann S.
        • Bovbjerg V.E.
        • Kushi L.
        • Cobb L.A.
        • Copass M.K.
        • Psaty B.M.
        • Lemaitre R.
        • Retzlaff B.
        • Knopp R.M.
        Dietary intake of long-chain omega-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.
        Am J Clin Nutr. 2000; 71: 208S-212S
        • Calo L.
        • Bianconi L.
        • Colivicchi F.
        • Lamberti F.
        • Loricchio M.L.
        • de Ruvo E.
        • Meo A.
        • Pandozi C.
        • Staibano M.
        • Santini M.
        N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery.
        J Am Coll Cardiol. 2005; 45: 1723-1728
        • Brouwer I.A.
        • Zock P.L.
        • Wever E.F.
        • Hauer R.N.
        • Camm A.J.
        • Bocker D.
        • Otto-Terlouw P.
        • Katan M.B.
        • Schouten E.G.
        Rationale and design of a randomised controlled clinical trial on supplemental intake of omega-3 fatty acids and incidence of cardiac arrhythmia.
        Eur J Clin Nutr. 2003; 57: 1323-1330
        • Leaf A.
        • Albert C.M.
        • Josephson M.
        • Steinhaus D.
        • Kluger J.
        • Kang J.X.
        • Cox B.
        • Zhang H.
        • Schoenfeld D.
        • Fatty Acid Antiarrhythmia Trial Investigators
        Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.
        Circulation. 2005; 112: 2762-2768
      2. Brouwer I. SOFA: Study on Omega-3 Fatty Acid and Ventricular Arrhythmia. Presented at the European Society of Cardiology Congress; September 5, 2005; Stockholm, Sweden.

        • Harper C.R.
        • Jacobson T.A.
        Usefulness of omega-3 fatty acids and the prevention of coronary heart disease.
        Am J Cardiol. 2005; 96: 1521-1529
        • Leaf A.
        • Kang J.X.
        • Xiao Y.F.
        • Billman G.E.
        n-3 Fatty acids in the prevention of cardiac arrhythmias.
        Lipids. 1999; 34: S187-S189
        • Hallaq H.
        • Smith T.W.
        • Leaf A.
        Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids.
        Proc Natl Acad Sci U S A. 1992; 89: 1760-1764
        • Nestel P.
        • Shige H.
        • Pomeroy S.
        • Cehun M.
        • Abbey M.
        • Raederstorff D.
        The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans.
        Am J Clin Nutr. 2002; 76: 326-330
        • Thies F.
        • Miles E.A.
        • Nebe-von-Caron G.
        • Powell J.R.
        • Hurst T.L.
        • Newsholme E.A.
        • Calder P.C.
        Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults.
        Lipids. 2001; 36: 1183-1193
        • Mozaffarian D.
        • Geelen A.
        • Brouwer I.A.
        • Geleijnse J.M.
        • Zock P.L.
        • Katan M.B.
        Effect of fish oil on heart rate in humans.
        Circulation. 2005; 112: 1945-1952
        • Cleland J.G.
        • Coletta A.P.
        • Lammiman M.
        • Witte K.K.
        • Loh H.
        • Nasir M.
        • Clark A.L.
        Clinical trials update from the European Society of Cardiology meeting 2005.
        Eur J Heart Fail. 2005; 7: 1070-1075
        • Tavazzi L.
        • Tognoni G.
        • Franzosi M.G.
        • Latini R.
        • Maggioni A.P.
        • Marchioli R.
        • Nicolosi G.L.
        • Porcu M.
        • GISSI-HF Investigators
        Rationale and design of the GISSI Heart Failure trial.
        Eur J Heart Fail. 2004; 6: 635-641